|
HDGFRP3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.41139999999085E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.23409999996937E-07 |
| Normal-vs-Stage2 |
2.047700E-04 |
| Normal-vs-Stage3 |
2.730300E-02 |
| Normal-vs-Stage4 |
2.596800E-01 |
| Stage1-vs-Stage2 |
8.718600E-01 |
| Stage1-vs-Stage3 |
3.797500E-02 |
| Stage1-vs-Stage4 |
3.833400E-01 |
| Stage2-vs-Stage3 |
1.461990E-01 |
| Stage2-vs-Stage4 |
3.122200E-01 |
| Stage3-vs-Stage4 |
9.897800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.34449999999553E-05 |
| Normal-vs-AfricanAmerican |
2.435100E-03 |
| Normal-vs-Asian |
3.839500E-02 |
| Caucasian-vs-AfricanAmerican |
2.449000E-01 |
| Caucasian-vs-Asian |
8.180400E-01 |
| AfricanAmerican-vs-Asian |
8.581000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.32320000091025E-08 |
| Normal-vs-Female |
5.761800E-02 |
| Male-vs-Female |
4.05199999997663E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.535100E-03 |
| Normal-vs-Extreme_Weight |
1.41470000047939E-07 |
| Normal-vs-Obese |
1.839800E-04 |
| Normal-vs-Extreme_Obese |
5.444500E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.188010E-01 |
| Normal_Weight-vs-Obese |
6.265400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.556800E-01 |
| Extreme_Weight-vs-Obese |
1.205620E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.138400E-01 |
| Obese-vs-Extreme_Obese |
2.204200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.430000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.413900E-04 |
| Normal-vs-Age(61-80Yrs) |
1.14179999999298E-06 |
| Normal-vs-Age(81-100Yrs) |
4.89159999994548E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.390250E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.762000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.614250E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.109030E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.652100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.707400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.98050004069006E-09 |
| Normal-VS-Type2 PRCC |
4.56470000020914E-07 |
| Normal-VS-KIRP CIMP |
5.521600E-02 |
| Normal-VS-Unclassified PRCC |
5.370000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.303000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.67310000298571E-08 |
| Type1 PRCC-VS-Unclassified PRCC |
1.987830E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.88050000005102E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
9.004800E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
9.576000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.71190999999071E-05 |
| Normal-vs-N1 |
5.640400E-01 |
| Normal-vs-N2 |
3.836200E-01 |
| N0-vs-N1 |
3.977400E-03 |
| N0-vs-N2 |
1.577690E-02 |
| N1-vs-N2 |
4.196000E-01 |
|
|
